NAD Research Insights
Dr. Matt discusses the ongoing debate surrounding NAD precursors like nicotinamide riboside and nicotinamide mononucleotide, highlighting the lack of consensus among experts about their bioavailability and effectiveness. He shares insights from his lab experiments, expressing skepticism about the claims of lifespan extension linked to these compounds. As the conversation shifts to sirtuins, the complexity of aging research becomes evident, emphasizing the need for further investigation in this intriguing field.In this clip
From this podcast
Tim Ferriss Show
The Life-Extension Episode With Dr. Matt Kaeberlein | The Tim Ferriss Show
Related Questions
How do nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) compare for NAD+ supplementation in the context of the episode The Life-Extension Episode With Dr. Matt Kaeberlein | The Tim Ferriss Show and the clip NAD Research Insights?
What do experts say about Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR) as discussed in the episode The Life-Extension Episode With Dr. Matt Kaeberlein | The Tim Ferriss Show and the clip NAD Research Insights?
How do nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) compare for NAD+ supplementation?